BioSpace News Archive

Solution Uses Deep Learning Technology Allowing Hospitals, Pharmaceutical Companies, and Cancer Centers to Offer Better and Quicker Diagnoses While Developing More Effective Drugs and Therapeutic Interventions

As a result of this milestone payment, Merrimack’s Board of Directors has authorized and declared a special cash dividend of $6.7 million on the Company’s common stock

The terms and conditions of the Offer are described in the Offer to Purchase dated Nov. 18, 2019 (the Offer to Purchase) and remain unchanged.

Ana Dutra and Eula Adams bring their expertise to Harvest’s board as the company expands its leading national footprint

Patented ERASE-Seq approach delivers ultra-high sensitivity somatic mutation detection using molecular amplification pools (MAPs) and background error correction

Censa Pharmaceuticals, Inc. (‘Censa”) today announced positive results from its Phase 2 trial for CNSA-001 (sepiapterin), a potential new medicine for the treatment of phenylketonuria (PKU)

BioNovelus, Inc. (OTC: ONOV) announces that Trey Blalock joined the Company’s Advisory Board. BioNovelus’ Advisory Board seats individual entrepreneurs and senior Information Warfare, (IW), Cyber Security / Information Technology (IT) executives with business, government and technical expertise useful for assisting in identifying, integrating and growing acquired companies

Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® received a Bronze Best in Biz Award

John will also serve as a member of the Company’s Executive Committee reporting directly to President and CEO, Howard W. Robin.

Mr. Cohen has more than 18 years of U.S. and international marketing experience in the life sciences, medical device, and clinical diagnostics industries.